Role of impaired glucose tolerance in patients with acute myocardial infarction in relation to sex

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 9, 2014, Pages 467-473

  Se¸dkowska, Agnieszka ^a   Kowalczyk, Jacek ^a   Woźniak, Aleksandra ^a   Kurek, Tomasz ^a   Zielińska, Teresa ^a   Strojek, Krzysztof ^a   Gumprecht, Janusz ^a   Kalarus, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diabetes; Glucose; Mortality; Risk; Stroke

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; CAUSE OF DEATH; COMORBIDITY; DELAYED DIAGNOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

GLUCOSE BLOOD LEVEL;

AGED; BLOOD GLUCOSE; CAUSE OF DEATH; COMORBIDITY; DELAYED DIAGNOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84907685696     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2407     Document Type: Article

References (30)

1. Fox C, Larson M, Leip E, et al. Glycemic status and development of kidney disease. The Framingham Heart Study. Diabetes Care. 2005; 28: 2436-2440.
2. Kowalska I, Prokop J, Bachorzewska-Gajewska H, et al. Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as a predictor for coronary atherosclerosis. Diabetes Care. 2001; 24: 897-901.
3. Wlodarczyk A, Strojek K. Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. Obesity predicts coronary atherosclerosis and dysglycemia. Pol Arch Med Wewn. 2008; 118: 719-726.
4. Santos J, Almeida M, Ferreira J, et al. Glucose metabolism in non-diabetic patients with stable coronary artery disease. Rev Port Cardiol. 2006; 25: 39-53.
5. Wessani S, Gangopadhyay K, Patel J, et al. Should oral glucose tolerance testing be mandatory following acute myocardial infarction? Int J Clin Pract. 2007; 61: 680-683.
6. Egstrup M, Henriksen F, Høfsten D, et al. Prevalence of glucometabolic abnormalities in connection with myocardial infarction in a Danish coronary care unit. Ugeskr Laeger. 2008; 170: 942-946.
7. Bartnik M, Malmberg K, Norhammar A, et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004; 25: 1990-1997.
8. Schnell O, Standl E. Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocr Pract. 2006; 12: 16-19.
9. Opolski G, Strojek K, Kurzelewski M, et al. Cardiovascular therapy, diagnostic procedures, and control of risk factors in patients with diabetes or coronary artery disease in Poland: the Kardia-Pol registry. Pol Arch Med Wewn. 2012; 122: 413-421.
10. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002; 19: 708-723.
11. Dotevall A, Rosengren A, Bartnik M, et al. Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease. Eur Heart J. 2007; 28: 310-315.
12. Rufino M, Barbero P, Hernández D, et al. Importance of oral glucose overload test (OGOT) at a specific clinic for advanced CRF stages IV and V. Nefrologia. 2007; 27: 30-37.
13. Tenere A, Norhammar A, Silveira A, et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care. 2003; 26: 2770-2776.
14. Čulić V, Mirić D, Kard I. Acute myocardial infarction: differing preinfarction and clinical features according to infarct site and gender. Int J Kardiol. 2003; 90: 189-196.
15. Reina A, Colmenero M, Aguayo de Hoyos E, et al. Gender differences in management and outcome of patients with acute myocardial infarction. Int J Cardiol. 2007; 116: 389-395.
16. Sielski J, Janion-Sadowska A, Sadowski M, et al. Differences in presentation, treatment, and prognosis in elderly patients with non-ST-segment elevation myocardial infarction. Pol Arch Med Wewn. 2012; 122: 253-261.
17. Heer T, Gitt A, Juenger C, et al. Gender differences in acute non-ST-segmen elevation myocardial infarction. Am J Cardiol. 2006; 98: 160-166.
18. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006; 332: 73-78.
19. Natarajan S, Liao Y, Cao G, et al. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med. 2003; 163: 1735-1740.
20. Kranječec D, Altabas V. Metabolic syndrome influencing infarct size and heart failure In patients with acute coronary syndrome - does gender matter? Endocr J. 2012; 59: 1065-1076.
21. Ryan T, Fisher S, Elder J, et al. Increased cardiovascular risk associated with reduced kidney function. Am J Nephrol. 2009; 29: 620-625.
22. Choi JS, Kim MJ, Kang YU, et al. Does gender influence the impact of impaired renal function on prognosis after ST-segment elevated myocardial infarction? Cardiol J. 2013; 20: 526-532.
23. Vasu S, Gruberg L, Brown D. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary interventions for acute myocardial infarction. Catheter Cardiovasc Interv. 2007; 70: 701-705.
24. Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology. 2006; 67: 224-228.
25. Kisialiou A, Grella R, Carrizzo A, et al. Risk factors and acute ischemic stroke subtypes. J Neurol Sci. 2014; 339: 41-46.
26. Park HS, Kang M, Huh J. Recent epidemiological trends of stroke. J Korean Neurosurg Soc. 2008; 43: 16-20.
27. Nakamura Y, Suzuki T, Sasano H. Estrogen actions and in situ synthesis in human vascular smooth muscle cells and their correlation with atherosclerosis. J Steroid Biochem Mol Biol. 2005; 93: 263-268.
28. Losordo D, Kearney M, Kim E, et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994; 89: 1501-1510.
29. Tostes R, Nigro D, Fortes Z, Carvalho M. Effects of estrogen on the vascular system. Braz J Med Biol Res. 2003; 36: 1143-58.
30. Elsayed E, Tighiouart H, Weiner D, et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis. 2008; 52: 49-57.